Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Estimating individualized treatment regimes from crossover designs.

Nguyen CT, Luckett DJ, Kahkoska AR, Shearrer GE, Spruijt-Metz D, Davis JN, Kosorok MR.

Biometrics. 2019 Nov 19. doi: 10.1111/biom.13186. [Epub ahead of print]

PMID:
31743424
2.

On the Use of Optimal Transportation Theory to Recode Variables and Application to Database Merging.

Gares V, Dimeglio C, Guernec G, Fantin R, Lepage B, Kosorok MR, Savy N.

Int J Biostat. 2019 Sep 14. pii: /j/ijb.ahead-of-print/ijb-2018-0106/ijb-2018-0106.xml. doi: 10.1515/ijb-2018-0106. [Epub ahead of print]

PMID:
31527293
3.

Biclustering via sparse clustering.

Helgeson ES, Liu Q, Chen G, Kosorok MR, Bair E.

Biometrics. 2019 Aug 19. doi: 10.1111/biom.13136. [Epub ahead of print]

PMID:
31424089
4.

Longitudinal Phenotypes of Type 1 Diabetes in Youth Based on Weight and Glycemia and Their Association With Complications.

Kahkoska AR, Nguyen CT, Adair LA, Aiello AE, Burger KS, Buse JB, Dabelea D, Dolan LM, Malik FS, Mottl AK, Pihoker C, Reboussin BA, Sauder KA, Kosorok MR, Mayer-Davis EJ.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6003-6016. doi: 10.1210/jc.2019-00734.

PMID:
31290977
5.

Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial.

Kahkoska AR, Lawson MT, Crandell J, Driscoll KA, Kichler JC, Seid M, Maahs DM, Kosorok MR, Mayer-Davis EJ.

JAMA Netw Open. 2019 May 3;2(5):e195137. doi: 10.1001/jamanetworkopen.2019.5137.

6.

Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics.

Yazdani A, Yazdani A, Elsea SH, Schaid DJ, Kosorok MR, Dangol G, Samiei A.

BMC Genomics. 2019 May 21;20(1):395. doi: 10.1186/s12864-019-5772-4.

7.

Precision Medicine.

Kosorok MR, Laber EB.

Annu Rev Stat Appl. 2019 Mar;6:263-286. doi: 10.1146/annurev-statistics-030718-105251.

PMID:
31073534
8.

Weighted NPMLE for the Subdistribution of a Competing Risk.

Bellach A, Kosorok MR, Rüschendorf L, Fine JP.

J Am Stat Assoc. 2019;114(525):259-270. doi: 10.1080/01621459.2017.1401540. Epub 2018 Jul 9.

9.

Cystic fibrosis program characteristics associated with adoption of 2013 infection prevention and control recommendations.

Stoudemire W, Jiang X, Zhou JJ, Maykowski P, Kosorok MR, Muhlebach MS, Saiman L.

Am J Infect Control. 2019 Sep;47(9):1090-1095. doi: 10.1016/j.ajic.2019.03.015. Epub 2019 Apr 27.

PMID:
31036402
10.

Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.

Kahkoska AR, Adair LA, Aiello AE, Burger KS, Buse JB, Crandell J, Maahs DM, Nguyen CT, Kosorok MR, Mayer-Davis EJ.

Pediatr Diabetes. 2019 Aug;20(5):556-566. doi: 10.1111/pedi.12856. Epub 2019 Apr 29.

PMID:
30972889
11.

An extended proportional hazards model for interval-censored data subject to instantaneous failures.

Withana Gamage PW, Chaudari M, McMahan CS, Kim EH, Kosorok MR.

Lifetime Data Anal. 2020 Jan;26(1):158-182. doi: 10.1007/s10985-019-09467-z. Epub 2019 Feb 23.

PMID:
30796598
12.

Prospects and challenges for clinical decision support in the era of big data.

Naqa IE, Kosorok MR, Jin J, Mierzwa M, Ten Haken RK.

JCO Clin Cancer Inform. 2018;2. doi: 10.1200/CCI.18.00002. Epub 2018 Nov 9.

13.

FEATURE ELIMINATION IN KERNEL MACHINES IN MODERATELY HIGH DIMENSIONS.

Dasgupta S, Goldberg Y, Kosorok MR.

Ann Stat. 2019 Feb;47(1):497-526. doi: 10.1214/18-AOS1696.

PMID:
30559548
14.

The Change-Plane Cox Model.

Wei S, Kosorok MR.

Biometrika. 2018 Dec;105(4):891-903. doi: 10.1093/biomet/asy050. Epub 2018 Oct 17.

15.

Multistate recursively imputed survival trees for time-to-event data analysis: an application to AIDS and mortality post-HIV infection data.

Tapak L, Kosorok MR, Sadeghifar M, Hamidi O.

BMC Med Res Methodol. 2018 Nov 13;18(1):129. doi: 10.1186/s12874-018-0596-5.

16.

Double Sparsity Kernel Learning with Automatic Variable Selection and Data Extraction.

Chen J, Zhang C, Kosorok MR, Liu Y.

Stat Interface. 2018;11(3):401-420. doi: 10.4310/SII.2018.v11.n3.a1.

17.

Discussion of Laber et al. "Optimal treatment allocations in space and time for on-line control of an emerging infectious disease".

Lawson MT, Cho H, Choudhury A, Cui Y, Jiang X, Pokaprakarn T, Kosorok MR.

J R Stat Soc Ser C Appl Stat. 2018 Aug;67(4):779-780. Epub 2018 Jul 18. No abstract available.

18.

Stratification of the risk of bipolar disorder recurrences in pregnancy and postpartum.

Di Florio A, Gordon-Smith K, Forty L, Kosorok MR, Fraser C, Perry A, Bethell A, Craddock N, Jones L, Jones I.

Br J Psychiatry. 2018 Sep;213(3):542-547. doi: 10.1192/bjp.2018.92.

19.

Study design with staggered sampling times for evaluating sustained unresponsiveness to peanut sublingual immunotherapy.

Chaudhari M, Kim EH, Withana Gamage PW, McMahan CS, Kosorok MR.

Stat Med. 2018 Nov 30;37(27):3944-3958. doi: 10.1002/sim.7857. Epub 2018 Jul 5.

PMID:
29974494
20.

Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.

Liu Y, Wang Y, Kosorok MR, Zhao Y, Zeng D.

Stat Med. 2018 Nov 20;37(26):3776-3788. doi: 10.1002/sim.7844. Epub 2018 Jun 5.

21.

Goodness-Of-Fit Test for Nonparametric Regression Models: Smoothing Spline ANOVA Models as Example.

Teran Hidalgo SJ, Wu MC, Engel SM, Kosorok MR.

Comput Stat Data Anal. 2018 Jun;122:135-155. doi: 10.1016/j.csda.2018.01.004. Epub 2018 Jan 31.

22.

Surveying Cystic Fibrosis Care Centers to Assess Adoption of Infection Prevention and Control Recommendations.

Saiman L, Zhou JJ, Jiang X, Kosorok MR, Muhlebach MS.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):647-651. doi: 10.1017/ice.2018.72. Epub 2018 Apr 15.

PMID:
29655374
23.

LIBERTI: A SMART study in plastic surgery.

Hibbard JC, Friedstat JS, Thomas SM, Edkins RE, Hultman CS, Kosorok MR.

Clin Trials. 2018 Jun;15(3):286-293. doi: 10.1177/1740774518762435. Epub 2018 Mar 25.

24.

Estimating individualized treatment rules for ordinal treatments.

Chen J, Fu H, He X, Kosorok MR, Liu Y.

Biometrics. 2018 Sep;74(3):924-933. doi: 10.1111/biom.12865. Epub 2018 Mar 13.

25.

Residual Weighted Learning for Estimating Individualized Treatment Rules.

Zhou X, Mayer-Hamblett N, Khan U, Kosorok MR.

J Am Stat Assoc. 2017;112(517):169-187. doi: 10.1080/01621459.2015.1093947. Epub 2017 May 3.

26.

Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.

Butler EL, Laber EB, Davis SM, Kosorok MR.

Biometrics. 2018 Mar;74(1):18-26. doi: 10.1111/biom.12743. Epub 2017 Jul 25.

27.

Comment.

Chen J, Liu Y, Zeng D, Song R, Zhao Y, Kosorok MR.

J Am Stat Assoc. 2016;111(515):942-947. doi: 10.1080/01621459.2016.1200914. Epub 2016 Oct 18.

28.

Composite large margin classifiers with latent subclasses for heterogeneous biomedical data.

Chen G, Liu Y, Shen D, Kosorok MR.

Stat Anal Data Min. 2016 Apr;9(2):75-88. Epub 2016 Jan 8.

29.

Reinforcement Learning Trees.

Zhu R, Zeng D, Kosorok MR.

J Am Stat Assoc. 2015;110(512):1770-1784. Epub 2015 Apr 16.

30.

Personalized Dose Finding Using Outcome Weighted Learning.

Chen G, Zeng D, Kosorok MR.

J Am Stat Assoc. 2016;111(516):1509-1521. doi: 10.1080/01621459.2016.1148611. Epub 2017 Jan 4.

31.

ASYMPTOTICS FOR CHANGE-POINT MODELS UNDER VARYING DEGREES OF MIS-SPECIFICATION.

Song R, Banerjee M, Kosorok MR.

Ann Stat. 2016 Feb;44(1):153-182. Epub 2015 Dec 10.

32.

Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.

Laber EB, Zhao YQ, Regh T, Davidian M, Tsiatis A, Stanford JB, Zeng D, Song R, Kosorok MR.

Stat Med. 2016 Apr 15;35(8):1245-56. doi: 10.1002/sim.6783. Epub 2015 Oct 28.

33.

Penalized Q-Learning for Dynamic Treatment Regimens.

Song R, Wang W, Zeng D, Kosorok MR.

Stat Sin. 2015 Jul;25(3):901-920.

34.

New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Zhao YQ, Zeng D, Laber EB, Kosorok MR.

J Am Stat Assoc. 2015;110(510):583-598.

35.

Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Zhao YQ, Zeng D, Laber EB, Song R, Yuan M, Kosorok MR.

Biometrika. 2015 Mar 1;102(1):151-168.

36.

Comment on "Dynamic treatment regimes: technical challenges and applications"

Goldberg Y, Song R, Zeng D, Kosorok MR.

Electron J Stat. 2014;8(1):1290-1300.

37.

University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (morning session).

Anderson K, Joffe M, Kosorok MR.

Clin Trials. 2014 Aug;11(4):418-425. Epub 2014 Jul 22. No abstract available.

38.

The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission.

Holdsworth La E, Zhu R, Hassmiller Lich K, Ellis AR, Swartz MS, Kosorok MR, Morrissey JP.

Adm Policy Ment Health. 2015 May;42(3):332-42. doi: 10.1007/s10488-014-0573-1.

39.

Discussion of combining biomarkers to optimize patient treatment recommendations.

Zhao YQ, Kosorok MR.

Biometrics. 2014 Sep;70(3):713-6. doi: 10.1111/biom.12189. Epub 2014 May 30.

40.

Latent Supervised Learning.

Wei S, Kosorok MR.

J Am Stat Assoc. 2013 Jul 1;108(503). doi: 10.1080/01621459.2013.789695.

41.

Biclustering with heterogeneous variance.

Chen G, Sullivan PF, Kosorok MR.

Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12253-8. doi: 10.1073/pnas.1304376110. Epub 2013 Jul 8.

42.

Medical records-based postmarketing safety evaluation of rare events with uncertain status.

Cao H, LaVange LM, Heyse JF, Mast TC, Kosorok MR.

J Biopharm Stat. 2013;23(4):744-55. doi: 10.1080/10543406.2013.789886.

43.

Estimating Individualized Treatment Rules Using Outcome Weighted Learning.

Zhao Y, Zeng D, Rush AJ, Kosorok MR.

J Am Stat Assoc. 2012 Sep 1;107(449):1106-1118.

44.

An Exponential Bound for Cox Regression.

Goldberg Y, Kosorok MR.

Stat Probab Lett. 2012 Jul;82(7):1267-1272.

45.

Medical records-based postmarketing safety evaluation of rare events with uncertain status.

Cao H, LaVange LM, Heyse JF, Mast TC, Kosorok MR.

J Biopharm Stat. 2013;23(1):201-12. doi: 10.1080/10543406.2013.735783.

46.
47.

Recursively Imputed Survival Trees.

Zhu R, Kosorok MR.

J Am Stat Assoc. 2012;107(497):331-340. Epub 2011 Dec 6.

48.

A framework for understanding cancer comparative effectiveness research data needs.

Carpenter WR, Meyer AM, Abernethy AP, Stürmer T, Kosorok MR.

J Clin Epidemiol. 2012 Nov;65(11):1150-8. doi: 10.1016/j.jclinepi.2012.06.005.

49.

Q-LEARNING WITH CENSORED DATA.

Goldberg Y, Kosorok MR.

Ann Stat. 2012 Feb 1;40(1):529-560.

50.

Data for cancer comparative effectiveness research: past, present, and future potential.

Meyer AM, Carpenter WR, Abernethy AP, Stürmer T, Kosorok MR.

Cancer. 2012 Nov 1;118(21):5186-97. doi: 10.1002/cncr.27552. Epub 2012 Apr 19. Review.

Supplemental Content

Loading ...
Support Center